No Data
No Data
Harmony Biosciences Executive Resigns, Subsidiary Renamed
Amended: FDA Denies Citizen Petition For Harmony Biosciences' Wakix
Harmony Biosciences Says FDA Denies Short Seller Claims Over Narcolepsy Drug Safety
By Michael Susin Harmony Biosciences Holdings on Tuesday said the U.S. Food and Drug Administration denied a citizen petition filed by short seller which claimed there were safety issues around its n
Express News | FDA Confirms Favorable Benefit-Risk Profile Of WAKIX; Harmony Biosciences Plans To Launch At Least One New Product Or Indication Annually Over Next Five Years; Denial Of Citizen Petition Confirms WAKIX's Safety And Efficacy For EDS And Cataplexy In...
Express News | Harmony Biosciences: On Track Toward Filing Snda for Wakix in Idiopathic Hypersomnia Later This Year
Express News | Harmony Biosciences: Confirm Our Outlook Wakix Represents Bln-Dollar Plus Market Opportunity in Adult Narcolepsy
No Data